|3 Months||YTD||1 Year||3 Year||Since
|CG Core Total Return Fund (Inst)||5.35%||9.93%||17.80%||15.36%||9.62%|
|Bloomberg Barclays Intermediate Government/Credit Index||0.21%||-0.76%||-0.96%||0.91%||1.60%|
|60% Russell 1000 & 40% Barclays Capital Interm Govt Credit||4.50%||5.94%||10.01%||10.46%||7.93%|
|Russell 1000 Total Return||7.42%||10.49%||17.76%||17.07%||12.12%|
Institutional Class Gross Expense Ratios: 4.61%
Institutional Class Net Expense Ratios***: 1.01%
*Inception of the Fund is 12/31/13.
Performance data quoted represent past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance of the Fund may be lower or higher than the performance quoted. For most recent month-end performance, please call 1-855-460-2838. Investment performance reflects a fee waiver in effect. In the absence of such waivers, total returns would be reduced.
Returns for periods less than one year are not annualized.
**The Russell 1000 Index (R1000) and Barclays Capital Intermediate Government Credit Index (BCIGC) are the CG Core Total Return Fund benchmarks. The Russell 1000 measures the performance of the mid- to large-cap segment of the U.S. equity universe. It is a subset of the Russell 3000® Index and includes approximately 1000 of the largest securities based on a combination of their market cap and current index membership. The Russell 1000 represents approximately 92% of the U.S. market. The Barclays Capital Intermediate Government Credit Index measures the performance of short to intermediate (1-10 year) government and corporate fixed rate debt issues and is an unmanaged index and includes fixed rate debt issues rated investment grade or higher. The 60%R1000/40%BCIGC is 60/40 mix of the Russell 1000 Index and Barclays Capital Intermediate Government Credit Index. You cannot invest directly in an index.
***The advisor has contractually agreed to waive fees and expenses through February 28, 2028.
805 Third Avenue, Suite 1120 New York, NY 10022
©Copyright 2017 All Rights Reserved.